- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Neurogene (NGNE)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 71.34 mm | 71.34 mm | 71.34 mm | 71.34 mm | 71.34 mm | 71.34 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 7.93 mm | 8.11 mm | 6.50 mm | 6.44 mm |
| Cash used (since last report) | n/a | n/a | 29.00 mm | 29.64 mm | 23.77 mm | 23.53 mm |
| Cash remaining | n/a | n/a | 42.34 mm | 41.70 mm | 47.57 mm | 47.81 mm |
| Runway (months of cash) | n/a | n/a | 5.3 | 5.1 | 7.3 | 7.4 |
| 13F holders | Current |
|---|---|
| Total holders | 90 |
| Opened positions | 28 |
| Closed positions | 25 |
| Increased positions | 31 |
| Reduced positions | 17 |
| 13F shares | Current |
|---|---|
| Total value | 364.05 bn |
| Total shares | 17.81 mm |
| Total puts | 241.20 k |
| Total calls | 103.20 k |
| Total put/call ratio | 2.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Samsara BioCapital | 1.72 mm | $44.30 mm |
| Samsara BioCapital | 1.72 mm | $39.25 bn |
| BLK BlackRock | 1.52 mm | $34.66 bn |
| RTW Investments | 1.35 mm | $30.87 bn |
| Redmile | 1.32 mm | $30.17 bn |
| Casdin Capital | 1.30 mm | $29.61 bn |
| EcoR1 Capital | 1.27 mm | $29.06 bn |
| FMR | 860.33 k | $19.67 bn |
| Commodore Capital | 800.00 k | $18.29 bn |
| Baker Bros. Advisors | 674.45 k | $15.42 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Jun 25 | Noonberg Sarah B. | NQSO Common Stock | Grant | Acquire A | No | No | 20.4 | 12,050 | 245.82 k | 12,050 |
| 12 Jun 25 | Rohan Palekar | NQSO Common Stock | Grant | Acquire A | No | No | 20.4 | 12,050 | 245.82 k | 12,050 |
| 12 Jun 25 | Cory S. Freedland | NQSO Common Stock | Grant | Acquire A | No | No | 20.4 | 12,050 | 245.82 k | 12,050 |
| 12 Jun 25 | Robert Keith Woods | NQSO Common Stock | Grant | Acquire A | No | No | 20.4 | 12,050 | 245.82 k | 12,050 |
| 12 Jun 25 | Robert Baffi | NQSO Common Stock | Grant | Acquire A | No | No | 20.4 | 12,050 | 245.82 k | 12,050 |